Professional Documents
Culture Documents
3 Causal Models Part I: Sufficient Causes: Matthew Fox Advanced Epidemiology
3 Causal Models Part I: Sufficient Causes: Matthew Fox Advanced Epidemiology
3 Causal Models Part I: Sufficient Causes: Matthew Fox Advanced Epidemiology
Matthew Fox
Advanced Epidemiology
1
2
Review of This Morning
“Modern” epidemiology
Goal of etiologic research
– Valid and precise estimate of the effect of exposure
on disease
Why not everything is as we were taught
– Statistics
Review of study designs, measure of effect
– Odds ratios and case-control sampling
– Hopefully changed a few minds (and set the tone)
3
This Session
Why are we in this business?
– What is the goal of epi investigations?
Things may have missed in intro epi
– How causal models and causal inference
helps clarify what we do and how we do it
Sufficient Causes Model
– Rothman’s Model (Sufficient Cases Model)
4
I turn on a light switch and the light
doesn’t go on. The globe (bulb?) is
burned out.
5
I turn on a light switch and the
light does go on.
6
Is there any disease for which
all cases are attributable to one
and only one cause?
7
Smoking causes lung cancer.
So why doesn’t every smoker get lung
cancer?
8
Is the occurrence of disease
deterministic or random within
what we know?
9
What is a “strong” risk factor?
What determines strength?
10
Why study causal models?
Helps understand why we do what we do
– What do we mean when we say that smoking
causes lung cancer?
Gives meaning to our measures of effect
– Theoretical and practical
Helps clarify important epidemiologic
concepts
11
A definition of a cause
An antecedent event, characteristic, or
condition that was necessary for the
occurrence of disease at the time it
occurred all other things being fixed
– Antecedent
– Necessary
– At the time it occurred
– Other things fixed
12
The Sufficient Cause Model
U Ken Rothman
C
13
History
15 D
The Sufficient Cause Model
17
Sufficient Causes
Minimally sufficient
– Each sufficient cause has a unique set of components and
none is extraneous
Necessary cause
– Component cause appearing in all sufficient causes for a
disease
– Poole proposes “universally necessary”
Complementary component causes
– Set of component causes required to complete a sufficient
cause, aside from one (exposure)
18
How much do we know?
19
So what might HIV infection look
like?
One SCM (pie) might be:
– Exposed to HIV through sex
– Unvaccinated (OK for now), no natural immunity
– No condom use
– Why doesn’t everyone exposed through sex get HIV? U
Circumcision? STDs? Genetic factors? No use of microbicide?
Is each component necessary?
– If so, take away one and you prevent disease
– Must be more causes than just the HIV virus
Other SCMs exist
– Mother to child, transfusion, needle stick, etc.
20
The Sufficient Cause Model
21 D
Disease and Causation
22
Component Causes (Exposures)
Component causes (i.e. exposures we
might want to study) have attributes
– Dose
– Duration
– Induction period (NOT LATENCY)
Specifying the attributes
improves the resolving
power of the study
23
Does smoking cause lung
cancer?
Smoking is too imprecise
– How much for how long? What type?
– Starting at what age?
Infinite combinations
– Each might have a different risk
Ignoring the attributes means we are lump all
exposures (from 1 lifetime cigarette to a 10
packs a day) together as exposed
– This biases towards no effect!
24
Dose attributes
25
Duration attributes
Total time of exposure
– years employed
Biologically relevant time of exposure
– Smoking before first pregnancy
Time of exposure beyond a minimum
– Years of driving after age 25
Time of exposure after gathering another
component cause
– HIV infection after HPV infection
26
Take home message 2:
To study effects of exposures, the
exposures must be precisely defined
27
Induction period attributes
29
Induction Time Example
Diethylstilbestrol, adenocarcinoma of the vagina
– A synthetic non-steroidal estrogen, given to pregnant women to prevent
miscarriage (’40s-’70s)
– Exposure is known to have occurred during gestation
– Cancer occurs in the offspring between 15-30 years of age
Other processes assumed to occur in the interim
– Other components in the causal pie still occur
– Adolescent hormonal activity may be one
If outcome can’t occur before 10 years, don’t include 1st
10 years of person-time
– Similar to immortal person-time
30
What about promoters or
catalysts?
Catalyst of diseases
– Anything that speeds up (or slows down) the
occurrence of a disease that would occur anyway
Are they causes of disease?
– Remember the “at the time it occurred” part of the
definition of a cause
– Does it matter to you?
31
Applications of the sufficient cause
model
33
Strength is Determined by
Complements
34
Imagine a gene-environment
interaction
G
U U
E
Phenylketonuria (PKU) - a genetic disorder characterized by a deficiency
in the enzyme to metabolize the amino acid phenylalanine. Untreated, it can
cause problems with brain development. However, PKU is a rare genetic
diseases that can be controlled by diet, one low in phenylalanine.
35
Imagine a gene-environment
interaction
36
Imagine a gene-environment
interaction
Exposed
70% get disease Unexposed
G G (10% U + G G 10% get disease
U E U E U U (10% U)
60% U/G/E)
G G G G
U E U E U U
G G G G
U E U E U U
RR = 70%/10% = 7
37
Imagine a gene-environment
interaction
38
Imagine a gene-environment
interaction
Exposed
20% get disease Unexposed
(10% U + 10% get disease
10% U/G/E) (10% U)
G G
U E U
RR = 20%/10% = 2.0
39
Imagine a gene-environment
interaction
40
Imagine a gene-environment
interaction
Exposed
U U
50% get disease
U U Unexposed
(10% U + 40% get disease
40% U/G/E) (40% U)
G G
U E U
RR = 50%/40% = 1.25
41
Another example
Vaccines are usually extremely protective
– What we often call a strong protective effect
But what if we tested our vaccine in a population
where everyone had natural immunity?
– Lack of natural immunity is a piece in the pie (causal
complement)
– When it is common, the effect appears strong
– When it is rare, the effect appears weak
42
Take home message 5:
and
0.85
0.9
0.8 Assume same sample
% with spina bifida
0.7 0.65
0.55 size (N=100)
0.6
0.5 Folic Acid
0.35
0.4
0.25 No FA
0.3
0.2
0.05
0.1
RD = 0.2
0
RR=0.2 RR=0.63 RR=0.75
A B C
44
Illustrates arbitrariness of effects:
Effect of FA on: Neural tube closure
0.95
1
% with neural tube closure
0.9
0.75
0.8
0.65
0.7
0.6
0.45
0.5 Folic Acid
0.35
0.4 No FA
0.3
0.15
0.2
0.1
RD = 0.2
0
RR=1.3 RR=1.4 RR=2.3
Same A B C
45
Take home message 6:
46
Proportion of disease caused by…
48
Advantages of the SCM
Applies to disease mechanisms in
individuals
– Tells us about how disease occurs, not just what
caused it
Illustrates:
– How component causes act together
– Attributes of component causes
– How strength is function of complements
– The ubiquity of interaction
– Process of causation, although not complete
49
Disadvantages of the SCM
Cannot easily apply to populations
– Though our examples show can be used this way
Deterministic in nature
– Assumes no randomness to disease causation
– Doesn’t easily deal with continuous variables
Obscures importance of reference group
definition
– Comparison is between those with component cause
and those without the component cause under study
50
Disadvantages of the SCM
Difficult to assess validity of measures of
association
– No easy definition of bias
No distinction between mutable, immutable
variables
– Can sex can be a component cause?
Does not include temporal sequence
– Could be revised to do so
Mechanisms cannot be fully articulated
51